ramosetron has been researched along with ondansetron in 46 studies
Studies (ramosetron) | Trials (ramosetron) | Recent Studies (post-2010) (ramosetron) | Studies (ondansetron) | Trials (ondansetron) | Recent Studies (post-2010) (ondansetron) |
---|---|---|---|---|---|
194 | 94 | 83 | 3,380 | 1,216 | 994 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 11 (23.91) | 18.2507 |
2000's | 10 (21.74) | 29.6817 |
2010's | 22 (47.83) | 24.3611 |
2020's | 3 (6.52) | 2.80 |
Authors | Studies |
---|---|
Barnes, NM; Brady, CA; Butler, AS; Choo, SH; Cioffi, CL; Cohen, ML; Dobritsa, S; Earley, WG; Fitzpatrick, K; Guo, C; Guzzo, PR; Hassler, C; Manning, DD; Masih, L; Naginskaya, J; Ryan, KN; Sikkander, MI; Usyatinsky, A; Wierschke, JD; Zhang, Z | 1 |
Ito, H; Iwai, A; Kamato, T; Katsuyama, Y; Miyata, K; Nishida, A; Ohta, M; Tsutsumi, R; Yamano, M; Yuki, H | 1 |
Akuzawa, S; Ito, H; Kamato, T; Kiso, T; Miyata, K; Nishida, A; Tsutsumi, R; Yamano, M | 1 |
Honda, K; Ito, H; Kamato, T; Miyata, K; Nishida, A; Tsutsumi, R; Yamano, M; Yuki, H | 1 |
Ichikawa, S; Ishii, A; Karasawa, A; Kishibayashi, N; Yokoyama, T | 1 |
Akuzawa, S; Kamato, T; Miyata, K; Yamano, M | 1 |
Furuya, T; Kurihara, H; Miyata, K; Ohta, M; Suzuki, T; Tokunaga, T; Yanagisawa, I | 1 |
Mase, T; Miyata, K; Nagashima, S; Ohta, M; Suzuki, T; Tokunaga, T | 1 |
Kamato, T; Miyata, K; Nagakura, Y; Naitoh, Y; Yamano, M | 1 |
Tsukagoshi, S | 1 |
Kamato, T; Miyata, K; Nagakura, Y; Yamano, M | 1 |
Blower, PR; Endo, T; Hamaue, N; Hirafuji, M; Kitamura, N; Minami, M; Nemoto, M; Ogawa, T; Teramoto, Y; Yasuda, E | 1 |
Akutagawa, N; Ishioka, S; Ito, E; Kiya, T; Kudo, R; Sagae, S; Saito, T; Sugimura, M; Umemura, K | 1 |
Akamatsu, H; Mikawa, K; Nishina, K; Niwa, Y; Shiga, M | 1 |
Liu, DW; Liu, YY; Shan, XJ; Xie, XD; Zheng, ZD | 1 |
Ikeda, K; Kobayashi, N; Niwa, T; Noda, Y; Saito, M; Takagi, A; Yamamoto, S | 1 |
Ai, B; Dong, M; Han, X; He, X; Huang, D; Liu, P; Shi, Y; Yang, S; Zhang, C; Zhou, S | 1 |
Hashimoto, R; Ikeda, K; Kurokawa, N; Okamoto, Y; Takagi, T; Takenaka, M; Ueda, T; Uejima, E | 1 |
Choi, YS; Jeon, DH; Kwak, YL; Lee, JY; Shim, JK; Yoon, DH | 1 |
Bang, YJ; Chie, EK; Ha, SW; Im, SA; Jang, JY; Kim, K; Kim, SW; Kim, TY; Oh, DY | 1 |
Baek, YH; Kim, SC; Kim, SH; Kim, SI; Ok, SY | 1 |
Do, SH; Hwang, J; Ryu, J; So, YM | 1 |
Ayuhara, H; Okuyama, K; Ozeki, T; Takayanagi, R; Yamada, Y; Yokoyama, H; Yoshimoto, K | 1 |
Mraovic, B; Simurina, T | 1 |
Choi, SJ; Gwak, MS; Hahm, TS; Ko, JS | 1 |
Fujii, Y | 1 |
Chin, JH; Choi, DK; Choi, IC; Chung, CH; Lee, EH; Lim, OB; Ro, YJ | 1 |
Akhtar, S; Ansari, MM; Haleem, S; Khan, FA; Siddiqui, OA; Varshney, R | 1 |
Amagase, K; Horie, S; Iimori, M; Kato, S; Kitahara, Y; Matsumoto, K; Takeuchi, K; Utsumi, D; Yamanaka, N; Yasuda, M | 1 |
Byon, HJ; Jang, YE; Kim, HS; Kim, JT; Park, YH | 1 |
Goto, T; Mihara, T; Morita, S; Tojo, K; Uchimoto, K | 1 |
Baik, HJ; Do, SH; Han, JI; Hong, DM; Kim, HZ; Lee, JE; Lim, YJ; Min, KT; Park, HP; Ryu, JH | 1 |
Chai, WS; Cho, SH; Jin, HC; Kim, SH; Kim, YK; Lee, JH; Lee, SM; Park, SY | 1 |
Cao, G; Gao, C; Li, B; Lv, F; Wang, F; Wang, H; Wu, G; Xu, L | 1 |
Ahn, JS; Cho, YH; Jang, JS; Kang, JH; Kim, HJ; Kim, JS; Kim, SW; Kim, SY; Kim, YS; Ko, YH; Lee, HW; Lee, NR; Lee, SN; Lee, SR; Park, KU; Shin, SW; Song, EK; Yun, HJ | 1 |
Amagase, K; Horie, S; Kato, S; Matsumoto, K; Utsumi, D | 1 |
Choi, BM; Jeong, SW; Lee, EK; Lee, YH; Lim, YJ; Min, KT; Noh, GJ; Seo, JH | 1 |
Joo, J; Park, HJ; Park, S; Shin, SY | 1 |
Arora, MK; Borle, A; Gouda, D; Goudra, B; Makkar, JK; Singh, PM; Sinha, A; Trikha, A | 1 |
Abushouk, AI; Ahmed, H; Al Nahrawi, S; Attia, A; Awad, K; Elsherbeny, MY; Mustafa, SM | 1 |
Chaiwuttisak, A; Pinsornsak, P; Ruetiwarangkoon, C; Teeyaphudit, M | 1 |
Goto, T; Ka, K; Mihara, T; Yokoi, A | 1 |
Chen, Y; Deng, R; Li, Y; Ouyang, A; Zhou, J | 1 |
Kim, YS; Lee, HJ; Lee, SU | 1 |
Aizawa, F; Chuma, M; Goda, M; Hamano, H; Ishizawa, K; Izawa-Ishizawa, Y; Kanda, M; Murai, Y; Niimura, T; Okada, N; Yagi, K; Yoshida, A; Yoshioka, T; Zamami, Y | 1 |
Choi, SS; Kim, AR; Kim, H; Kim, YS; Lee, CH; Lee, MK; Oh, SK | 1 |
8 review(s) available for ramosetron and ondansetron
Article | Year |
---|---|
[A new antiemetic ramosetron hydrochloride].
Topics: Animals; Antiemetics; Antineoplastic Agents; Benzimidazoles; Granisetron; Guinea Pigs; Humans; Male; Nausea; Ondansetron; Serotonin Antagonists; Vomiting | 1997 |
Prevention of nausea and vomiting during termination of pregnancy.
Topics: Abortion, Therapeutic; Antiemetics; Benzimidazoles; Dexamethasone; Dilatation and Curettage; Droperidol; Drug Therapy, Combination; Female; Humans; Hydroxyzine; Metoclopramide; Ondansetron; Postoperative Nausea and Vomiting; Pregnancy; Propofol; Randomized Controlled Trials as Topic | 2010 |
Reevaluation of the effectiveness of ramosetron for preventing postoperative nausea and vomiting: a systematic review and meta-analysis.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Benzimidazoles; Female; Humans; Male; Middle Aged; Odds Ratio; Ondansetron; Postoperative Nausea and Vomiting; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Young Adult | 2013 |
Efficacy and safety of ramosetron versus ondansetron for postoperative nausea and vomiting after general anesthesia: a meta-analysis of randomized clinical trials.
Topics: Antiemetics; Benzimidazoles; Humans; Ondansetron; Postoperative Nausea and Vomiting; Randomized Controlled Trials as Topic | 2015 |
Efficacy of palonosetron in postoperative nausea and vomiting (PONV)-a meta-analysis.
Topics: Adult; Anesthesia, General; Antiemetics; Benzimidazoles; Granisetron; Humans; Isoquinolines; Ondansetron; Palonosetron; Postoperative Nausea and Vomiting; Quinuclidines; Randomized Controlled Trials as Topic; Serotonin Antagonists; Treatment Outcome | 2016 |
Dexamethasone combined with other antiemetics versus single antiemetics for prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy: An updated systematic review and meta-analysis.
Topics: Antiemetics; Benzimidazoles; Cholecystectomy, Laparoscopic; Dexamethasone; Drug Therapy, Combination; Granisetron; Humans; Isoquinolines; Metoclopramide; Ondansetron; Palonosetron; Postoperative Nausea and Vomiting; Quinuclidines; Randomized Controlled Trials as Topic | 2016 |
Comparative efficacy of ramosetron and ondansetron in preventing postoperative nausea and vomiting: An updated systematic review and meta-analysis with trial sequential analysis.
Topics: Antiemetics; Benzimidazoles; Humans; Ondansetron; Postoperative Nausea and Vomiting | 2017 |
Comparison of ramosetron and ondansetron for the prevention of postoperative nausea and vomiting in patients undergoing laparoscopic surgery: a meta-analysis of randomized controlled trials.
Topics: Adult; Benzimidazoles; Humans; Laparoscopy; Middle Aged; Ondansetron; Postoperative Nausea and Vomiting; Publication Bias; Randomized Controlled Trials as Topic; Risk | 2019 |
17 trial(s) available for ramosetron and ondansetron
Article | Year |
---|---|
[Effects of oral 5-HT3 antagonists on chemotherapy-induced emesis in patients with gynecologic cancers].
Topics: Administration, Oral; Antiemetics; Benzimidazoles; Carboplatin; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Genital Neoplasms, Female; Granisetron; Humans; Indoles; Middle Aged; Nausea; Ondansetron; Paclitaxel; Serotonin Antagonists; Tropisetron; Vomiting | 2000 |
[Effects of Nasea on prevention of gastrointestinal side effects caused by chemotherapeutic drugs].
Topics: Adult; Aged; Anorexia; Antiemetics; Antineoplastic Agents; Benzimidazoles; Female; Gastrointestinal Diseases; Humans; Injections, Intravenous; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Time Factors; Treatment Outcome; Vomiting | 2003 |
Ramosetron versus ondansetron in the prevention of chemotherapy-induced gastrointestinal side effects: A prospective randomized controlled study.
Topics: Adolescent; Adult; Aged; Anorexia; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Female; Humans; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Vomiting | 2007 |
Effect of ramosetron on patient-controlled analgesia related nausea and vomiting after spine surgery in highly susceptible patients: comparison with ondansetron.
Topics: Adolescent; Adult; Aged; Analgesia, Patient-Controlled; Benzimidazoles; Double-Blind Method; Female; Humans; Middle Aged; Ondansetron; Postoperative Nausea and Vomiting; Prospective Studies; Spinal Diseases | 2008 |
Comparison of ramosetron with ondansetron for prevention of postoperative nausea and vomiting in patients undergoing gynaecological surgery.
Topics: Adult; Aged; Antiemetics; Benzimidazoles; Double-Blind Method; Female; Gynecologic Surgical Procedures; Humans; Intraoperative Care; Middle Aged; Ondansetron; Patient Satisfaction; Postoperative Nausea and Vomiting; Prospective Studies; Treatment Outcome; Young Adult | 2009 |
Ramosetron versus ondansetron for the prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy.
Topics: Adult; Aged; Analysis of Variance; Antiemetics; Benzimidazoles; Chi-Square Distribution; Cholecystectomy, Laparoscopic; Double-Blind Method; Female; Humans; Male; Middle Aged; Ondansetron; Postoperative Nausea and Vomiting; Treatment Outcome | 2010 |
Comparison of the prophylactic anti-emetic efficacy of ramosetron and ondansetron in patients at high-risk for postoperative nausea and vomiting after total knee replacement.
Topics: Aged; Aged, 80 and over; Antiemetics; Arthroplasty, Replacement, Knee; Benzimidazoles; Female; Humans; Middle Aged; Ondansetron; Postoperative Nausea and Vomiting; Severity of Illness Index; Treatment Outcome | 2010 |
Prophylactic control of post-operative nausea and vomiting using ondansetron and ramosetron after cardiac surgery.
Topics: Aged; Analgesia, Patient-Controlled; Anesthesia; Antiemetics; Benzimidazoles; Cardiac Surgical Procedures; Double-Blind Method; Female; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Ondansetron; Pain, Postoperative; Postoperative Care; Postoperative Nausea and Vomiting | 2010 |
Comparison of ramosetron and ondansetron for control of post-operative nausea and vomiting following laparoscopic cholecystectomy.
Topics: Adult; Antiemetics; Benzimidazoles; Cholecystectomy, Laparoscopic; Female; Humans; Male; Ondansetron; Postoperative Nausea and Vomiting | 2010 |
Comparison of the efficacy of ramosetron and ondansetron in the prophylaxis of postoperative vomiting in children receiving fentanyl by patient-controlled analgesia after orthopedic surgery: a randomized controlled trial.
Topics: Adolescent; Analgesia, Patient-Controlled; Analgesics, Opioid; Antiemetics; Benzimidazoles; Child; Child, Preschool; Double-Blind Method; Female; Fentanyl; Humans; Male; Ondansetron; Orthopedic Procedures; Pain, Postoperative; Postoperative Nausea and Vomiting | 2013 |
A prospective, randomized, double-blind, and multicenter trial of prophylactic effects of ramosetronon postoperative nausea and vomiting (PONV) after craniotomy: comparison with ondansetron.
Topics: Adult; Aged; Antiemetics; Benzimidazoles; Craniotomy; Double-Blind Method; Female; Humans; Male; Middle Aged; Ondansetron; Pain, Postoperative; Postoperative Nausea and Vomiting; Prospective Studies; Treatment Outcome; Young Adult | 2014 |
Effects of prophylactic ramosetron and ondansetron on corrected QT interval during general anesthesia.
Topics: Adult; Aged; Anesthesia, General; Antiemetics; Benzimidazoles; Cholecystectomy, Laparoscopic; Dose-Response Relationship, Drug; Electrocardiography; Female; Humans; Long QT Syndrome; Male; Middle Aged; Ondansetron; Postoperative Nausea and Vomiting; Young Adult | 2014 |
Ramosetron Versus Ondansetron in Combination With Aprepitant and Dexamethasone for the Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: A Multicenter, Randomized Phase III Trial, KCSG PC10-21.
Topics: Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Benzimidazoles; Dexamethasone; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Morpholines; Nausea; Neoplasms; Ondansetron; Prospective Studies; Single-Blind Method; Treatment Outcome; Vomiting | 2015 |
Population pharmacokinetics and prophylactic anti-emetic efficacy of ramosetron in surgical patients.
Topics: Antiemetics; Benzimidazoles; Double-Blind Method; Female; Humans; Male; Middle Aged; Models, Biological; Ondansetron; Postoperative Nausea and Vomiting | 2016 |
Ramosetron versus ondansetron for postoperative nausea and vomiting in strabismus surgery patients.
Topics: Adolescent; Adult; Anesthesia, General; Antiemetics; Benzimidazoles; Double-Blind Method; Female; Humans; Incidence; Male; Middle Aged; Ondansetron; Patient Satisfaction; Postoperative Nausea and Vomiting; Prospective Studies; Strabismus; Time Factors; Treatment Outcome; Young Adult | 2016 |
Comparison of Ramosetron With Ondansetron for Prevention of Intrathecal Morphine-Induced Nausea and Vomiting After Primary Total Knee Arthroplasty: A Randomized Control Trial.
Topics: Aged; Anesthesia, Spinal; Antiemetics; Arthroplasty, Replacement, Knee; Benzimidazoles; Cost-Benefit Analysis; Double-Blind Method; Female; Humans; Injections, Spinal; Male; Middle Aged; Morphine; Narcotics; Ondansetron; Pain Management; Patient Satisfaction; Postoperative Nausea and Vomiting; Receptors, Serotonin, 5-HT3 | 2017 |
The effectiveness of ramosetron and ondansetron for preventing postoperative nausea and vomiting after arthroscopic rotator cuff repair: a randomized controlled trial.
Topics: Aged; Antiemetics; Arthroscopy; Benzimidazoles; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Ondansetron; Pain, Postoperative; Postoperative Nausea and Vomiting; Postoperative Period; Rotator Cuff; Severity of Illness Index; Time Factors; Treatment Outcome | 2020 |
21 other study(ies) available for ramosetron and ondansetron
Article | Year |
---|---|
Novel serotonin type 3 receptor partial agonists for the potential treatment of irritable bowel syndrome.
Topics: Animals; Cell Line; Disease Models, Animal; Humans; Imidazoles; Indoles; Irritable Bowel Syndrome; Mice; Microsomes, Liver; Receptors, Serotonin, 5-HT3; Serotonin 5-HT3 Receptor Agonists | 2011 |
Pharmacologic profile of (R)-5-[(1-methyl-3-indolyl)carbonyl]-4,5,6,7-tetrahydro-1H- benzimidazole hydrochloride (YM060), a potent and selective 5-hydroxytryptamine3 receptor antagonist, and its enantiomer in the isolated tissue.
Topics: Animals; Benzimidazoles; Dogs; Female; Granisetron; Guinea Pigs; Imidazoles; Indazoles; Male; Muscle, Smooth; Muscle, Smooth, Vascular; Myocardial Contraction; Ondansetron; Receptors, Adrenergic; Receptors, Histamine; Serotonin Antagonists; Stereoisomerism | 1991 |
Comparative study of the affinities of the 5-HT3 receptor antagonists, YM060, YM114 (KAE-393), granisetron and ondansetron in rat vagus nerve and cerebral cortex.
Topics: Animals; Benzimidazoles; Cerebral Cortex; Dose-Response Relationship, Drug; Electrophysiology; Granisetron; Kinetics; Male; Ondansetron; Rats; Rats, Wistar; Serotonin; Serotonin Antagonists; Vagus Nerve | 1995 |
Serotonin (5-HT)3-receptor antagonism of 4,5,6,7-tetrahydrobenzimidazole derivatives against 5-HT-induced bradycardia in anesthetized rats.
Topics: Animals; Benzimidazoles; Bradycardia; Colon; Disease Models, Animal; Dose-Response Relationship, Drug; Granisetron; Guinea Pigs; In Vitro Techniques; Indolizines; Injections, Intravenous; Male; Muscle Contraction; Muscle, Smooth; Ondansetron; Rats; Rats, Wistar; Serotonin; Serotonin Antagonists; Structure-Activity Relationship | 1994 |
Pharmacological properties of KF18259, a novel 5-HT3-receptor antagonist, in rats: inhibition of the distal colonic function.
Topics: Animals; Benzimidazoles; Cisplatin; Colon; Defecation; Gastric Emptying; Gastrointestinal Motility; Granisetron; Male; Ondansetron; Quinolines; Rats; Rats, Sprague-Dawley; Reflex; Serotonin; Serotonin Antagonists | 1993 |
Effect of serotonin (5-HT)3-receptor antagonists YM060, YM114 (KAE-393), ondansetron and granisetron on 5-HT4 receptors and gastric emptying in rodents.
Topics: Animals; Benzimidazoles; Cisplatin; Dose-Response Relationship, Drug; Gastric Emptying; Granisetron; Guinea Pigs; Male; Ondansetron; Rats; Rats, Wistar; Serotonin Antagonists | 1995 |
Novel 5-hydroxytryptamine (5-HT3) receptor antagonists. III. Pharmacological evaluations and molecular modeling studies of optically active 4,5,6,7-tetrahydro-1H-benzimidazole derivatives.
Topics: Animals; Benzimidazoles; Cisplatin; Crystallography, X-Ray; Defecation; Ferrets; Guinea Pigs; In Vitro Techniques; Magnetic Resonance Spectroscopy; Male; Molecular Conformation; Muscle Contraction; Ondansetron; Rats; Rats, Wistar; Serotonin Antagonists; Structure-Activity Relationship; Vomiting | 1996 |
Novel 5-hydroxytryptamine (5-HT3) receptor antagonists. IV. Synthesis and pharmacological evaluation of the oxidation products of (-)-(R)-5-[(1-methyl-1H-indol-3-yl)carbonyl] -4,5,6,7-tetrahydro-1H-benzimidazole hydrochloride (YM060: ramosetron).
Topics: Animals; Benzimidazoles; Colon; Guinea Pigs; In Vitro Techniques; Magnetic Resonance Spectroscopy; Male; Molecular Conformation; Muscle Contraction; Ondansetron; Oxidation-Reduction; Rats; Rats, Wistar; Serotonin; Serotonin Antagonists; Structure-Activity Relationship | 1996 |
Compounds possessing 5-HT3 receptor antagonistic activity inhibit intestinal propulsion in mice.
Topics: Adrenergic alpha-Agonists; Animals; Benzamides; Benzimidazoles; Bridged Bicyclo Compounds, Heterocyclic; Cholinesterase Inhibitors; Cisapride; Clonidine; Gastrointestinal Transit; Intestines; Male; Mice; Mice, Inbred C57BL; Neostigmine; Ondansetron; Piperidines; Receptors, Serotonin; Serotonin Antagonists | 1996 |
Effects of gastroprokinetic agents on gastroparesis in streptozotocin-induced diabetic rats.
Topics: Animals; Benzamides; Benzimidazoles; Blood Glucose; Cisapride; Diabetes Mellitus, Experimental; Gastric Emptying; Gastrointestinal Motility; Gastroparesis; Granisetron; Male; Morpholines; Ondansetron; Piperidines; Pyrroles; Rats; Rats, Wistar; Serotonin Antagonists; Serotonin Receptor Agonists; Vagotomy | 1997 |
Effects of various 5-HT3 receptor antagonists, granisetron, ondansetron, ramosetron and azasetron on serotonin (5-HT) release from the ferret isolated ileum.
Topics: Animals; Benzimidazoles; Dose-Response Relationship, Drug; Drug Interactions; Ferrets; Granisetron; Ileum; Male; Ondansetron; Receptors, Serotonin; Serotonin; Serotonin Antagonists | 1999 |
Effects of ondansetron, granisetron, ramosetron, and azasetron on human neutrophil functions.
Topics: Antiemetics; Benzimidazoles; Bridged Bicyclo Compounds, Heterocyclic; Chemotaxis, Leukocyte; Granisetron; Humans; Neutrophils; Ondansetron; Oxazines | 2002 |
Effects of serotonin-3 receptor antagonists on cytochrome P450 activities in human liver microsomes.
Topics: Benzimidazoles; Bridged Bicyclo Compounds, Heterocyclic; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Humans; Microsomes, Liver; Ondansetron; Oxazines; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists | 2006 |
[Comparison of antiemetic efficacy of 5-HT3 receptor antagonists in orthopedics cancer patients receiving high-dose chemotherapy].
Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Bone Neoplasms; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Female; Granisetron; Humans; Ifosfamide; Male; Middle Aged; Nausea; Ondansetron; Osteosarcoma; Prospective Studies; Serotonin 5-HT3 Receptor Antagonists; Vomiting | 2007 |
Ramosetron for the prevention of nausea and vomiting during 5-fluorouracil-based chemoradiotherapy for pancreatico-biliary cancer.
Topics: Adult; Aged; Antiemetics; Benzimidazoles; Biliary Tract Neoplasms; Chemotherapy, Adjuvant; Female; Fluorouracil; Humans; Male; Metoclopramide; Middle Aged; Nausea; Ondansetron; Pancreatic Neoplasms; Radiotherapy, Adjuvant; Vomiting | 2009 |
Receptor occupancy theory-based analysis of interindividual differences in antiemetic effects of 5-HT3 receptor antagonists.
Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Bridged Bicyclo Compounds, Heterocyclic; Drug Administration Schedule; Granisetron; Humans; Indoles; Models, Theoretical; Ondansetron; Oxazines; Serotonin 5-HT3 Receptor Antagonists; Treatment Outcome; Tropisetron; Vomiting | 2009 |
Matching groups for studying postoperative nausea and vomiting: should we care?
Topics: Antiemetics; Benzimidazoles; Humans; Ondansetron; Postoperative Nausea and Vomiting; Risk Factors | 2010 |
5-HT₃ receptor antagonists ameliorate 5-fluorouracil-induced intestinal mucositis by suppression of apoptosis in murine intestinal crypt cells.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Apoptosis Regulatory Proteins; Benzimidazoles; Colonic Neoplasms; Cytokines; Diarrhea; Dose-Response Relationship, Drug; Drug Interactions; Fluorouracil; Gastrointestinal Agents; Gene Expression Regulation; Immunosuppressive Agents; Intestinal Mucosa; Male; Mice; Mice, Inbred C57BL; Mucositis; Ondansetron; Serotonin 5-HT3 Receptor Agonists; Serotonin 5-HT3 Receptor Antagonists | 2013 |
5-HT3 receptors promote colonic inflammation via activation of substance P/neurokinin-1 receptors in dextran sulphate sodium-induced murine colitis.
Topics: Animals; Benzimidazoles; Colitis; Colon; Dextran Sulfate; Dose-Response Relationship, Drug; Inflammation; Male; Mice; Mice, Inbred C57BL; Ondansetron; Receptors, Neurokinin-1; Receptors, Serotonin, 5-HT3; Serotonin 5-HT3 Receptor Antagonists; Structure-Activity Relationship; Substance P | 2016 |
Effects of 5-HT
Topics: Acute Kidney Injury; Aged; Animals; Benzimidazoles; Cisplatin; Disease Models, Animal; Female; Granisetron; Humans; Kidney; Male; Mice; Middle Aged; Nausea; Ondansetron; Organic Cation Transport Proteins; Palonosetron; Renal Elimination; Retrospective Studies; Serotonin 5-HT3 Receptor Antagonists; Vomiting | 2021 |
Microbiological and Physicochemical Stability of Fentanyl, Oxycodone, Hydromorphone, Ketorolac, Ramosetron, and Ondansetron for Intravenous Patient-controlled Analgesia: An In Vitro Study.
Topics: Analgesia, Patient-Controlled; Analgesics, Opioid; Benzimidazoles; Fentanyl; Humans; Hydromorphone; Ketorolac; Ondansetron; Oxycodone; Pain, Postoperative | 2021 |